Serum but not cerebrospinal fluid levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 (IGFBP-3) are increased in Alzheimer's disease |
| |
Authors: | Per Johansson,Daniel Å berg,Jan-Ove Johansson,Niklas Mattsson,Oskar Hansson,Bo Ahré n,Jö rgen Isgaard,N. David Å berg,Kaj Blennow,Henrik Zetterberg,Anders Wallin,Johan Svensson |
| |
Affiliation: | 1. Department of Neuropsychiatry, Skaraborg Hospital, SE-521 85 Falköping, Sweden;2. Department of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, SE-413 45 Gothenburg, Sweden;3. Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at University of Gothenburg, SE-431 80 Mölndal, Sweden;4. Clinical Memory Research Unit, Department of Clinical Sciences, Skåne University Hospital, Lund University, SE-205 02 Malmö, Sweden;5. Department of Clinical Sciences, Lund University, SE-221 84, Sweden;6. UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK;g Department of Endocrinology, Skaraborg Hospital, SE-541 85 Skövde, Sweden |
| |
Abstract: | ![]()
|
| |
Keywords: | IGF-I IGFBP-3 Insulin Cerebrospinal fluid Alzheimer's disease Mild cognitive impairment AD biomarker |
本文献已被 ScienceDirect 等数据库收录! |
|